Susan Hasty, Publisher
Table of Contents . . . October 2nd, 2000Non-Subscriber - Summaries Only
Autoimmune Hepatitis - Type 1 Immune Disease is Marked by Antibodies for Soluble Liver Antigen
Adverse Drug Reactions - Gemcitabine/Etoposide Therapy Causes Hepatic Dysfunction in HBV+ Lung Cancer Patients
Interferon Therapy - Twice-Daily Interferon Regimen Clears Viral RNA But Increases Toxic Effects
Liver Transplantation - Piggyback Transplant Technique Benefits Patients More than Standard Method
Coinfection (HCV/HIV) - Hepatitis C Infection More of an Issue Now that HIV+ Patients are Living Longer
Interferon Therapy - Collaboration Will Develop PEGylated Natural Alpha Interferon to Treat Hepatitis C
Outbreaks - Hepatitis A Virus Outbreak Worsening in Maryland
Yellow Fever - United Nations Agency Campaign "Resounding Success"
Immunization - CDC Releases U.S. Vaccine Coverage Statistics
Immunization - Global Vaccine Fund To Assist 13 Developing Countries
Interferon Therapy - Pretreatment with Corticosteroids and Thymic Extract Studied in HBV Patients
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.